Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage

Karin J. Bosma, Spencer R. Andrei, Liora S. Katz, Ashley A. Smith, Jennifer C. Dunn, Valerie Ricciardi, Marisol Ramirez, Sharon Baumel-Alterzon, William A. Pace, Darian T. Carroll,

Molecular Metabolism · 2021 · 24 citations · 56 references

DOIFull text

Open access

References

56